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Enterococcus faecium has undergone a transition to a multidrug-resistant nosocomial pathogen. )e population structure of E.
faecium is characterized by a sharp distinction of clades, where the hospital-adapted lineage is primarily responsible for bac-
teremia. So far, factors that were identified in hospital-adapted strains and that promoted pathogenesis of nosocomial E. faecium
mainly play a role in adherence and biofilm production, while less is known about factors contributing to survival in blood. )is
study identified a gene cluster, which includes genes encoding bacterial Toll/interleukin-1 receptor- (TIR-) domain-containing
proteins (TirEs). )e cluster was found to be unique to nosocomial strains and to be located on a putative mobile genetic element
of phage origin. )e three genes within the cluster appeared to be expressed as an operon. Expression was detected in bacterial
culture media and in the presence of human blood. TirEs are released into the bacterial supernatant, and TirE2 is associated with
membrane vesicles. Furthermore, the tirE-gene cluster promotes bacterial proliferation in human blood, indicating that TirE may
contribute to the pathogenesis of bacteremia.
1. Introduction
In the last three decades, the Gram-positive bacterium
Enterococcus has undergone a pronounced transition from
a human gut commensal to a multidrug-resistant nosoco-
mial opportunistic pathogen [1–3]. Enterococcal infections
are mainly caused by Enterococcus faecium and E. faecalis
[4, 5]. E. faecalis historically accounted for 80–90% of the
clinical isolates, and 5–10% used to be E. faecium [6].
However, E. faecium has risen to be the cause of 34% of the
enterococcal infections [7].
)e clade structure of E. faecium displays distinct
groups, where commensal strains fall into clade B and
hospital-associated strains into clade A [8, 9]. Enterococcal
genomes are highly plastic and are able to acquire and
exchange large fragments of DNA. Especially in clade A, the
cumulative adaptive gene uptake is reflected by a larger
genome size [8].
)e most severe infection caused by E. faecium is
endocarditis, and additionally, E. faecium often causes
urinary tract infection and bacteremia [4]. Infections are
established upon translocation to the bloodstream, through
the perturbed intestine or uptake from the contaminated
hospital environment or skin [4].
)e host innate immune system provides the first line of
defense against microbial attacks. It is induced through the
recognition of highly conserved microbial structures,
namely, pathogen-associated molecular patterns (PAMPs),
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by pattern recognition receptors, among which Toll-like
receptors (TLRs) are predominant [10, 11]. )e recogni-
tion of PAMPs by TLRs mediates antimicrobial responses,
such as phagocytosis and microbial killing. Out of ten
presently described human TLRs, TLR2 has been identified
to be central in recognition of E. faecium [12]. MyD88 is the
key intracellular adaptor for TLR2, and stimulation of its
intracellular pathway leads to NF-kB activation, resulting in
proinflammatory mediator expression [13–15]. Since the
initial recognition of a pathogen by immune cells is crucial
for all subsequent antimicrobial responses of the host, in-
terference with the innate immune response is a significant
advantage for invasive bacteria, and counteraction is
through molecular mimicry and immune evasion factors
[11, 16].
Bacterial TIR- (Toll/interleukin-1 receptor-) domain-
containing proteins structurally mimic host domains,
which are crucial for protein-protein interaction in TLR
signaling cascade adaptors [17, 18]. Immune evasive
properties of bacterial TIR proteins were first described in
Salmonella enterica, where the protein was named “TlpA”
(TIR-like protein A) [18]. Since then, TIR proteins with
immune evasive properties have been described in a range of
Gram-negative and Gram-positive bacteria, including
Staphylococcus aureus [19, 20] and E. faecalis [21]. In general,
bacterial TIR proteins negatively interfere with TLR sig-
naling through adaptor blockade or adaptor degradation
[22]. TIR-domain-containing proteins share several amino
acid sequence motifs, such as boxes 1 and 2 as well as the
WxxxE motif [22, 23]. )e TIR-domain-containing protein
in E. faecalis (TcpF) has been described to be predominant
among urinary tract infection isolates, attenuate MyD88-
mediated signaling, and promote bacterial survival within
macrophages [21, 24]. In the closely related E. faecium,
however, TIR-domain-containing proteins have not been
described yet. )e virulence factors so far identified in
E. faecium are mainly associated with adhesion, aggregation,
growth, and biofilm formation [25–42]. Identification of
virulence factors might reveal targets for novel therapeutic
approaches.
Our aims were to identify TIR-domain-containing
proteins in E. faecium (TirEs), compare their prevalence
in nosocomial versus community-associated strains, explore
their genetic context, and study their function.
2. Materials and Methods
2.1. Bacterial Strains, Plasmids, and Growth Conditions.
Prevalence screening for tirE genes and the gene hp1 be-
tween the two tirE genes was performed in a diverse
E. faecium collection. )e strains were of different geo-
graphical origin (24 countries), the main countries being the
Netherlands (587 isolates), Latvia (96 isolates), Norway (88
isolates), Switzerland (82 isolates), Greece (79 isolates),
Germany (61 isolates), Portugal (56 isolates), and Denmark
(40 isolates).)e total of 1194 strains consist of blood culture
(161 isolates), other hospital-associated isolates (meaning
feces, urine, or wound, 875 isolates), and human community
(158 isolates) isolates (Table S1).
E. faecium and Escherichia coli strains as well as plasmids
used for laboratory experiments in this study are listed in
Table S2. E. faecium was grown in the brain heart infusion
(BHI) medium or Luria-Bertani (LB) medium at 30°C or
37°C with shaking; E. coli strains were grown in the LB
medium or LB supplemented with 20mM glucose at 37°C
with shaking.
For E. faecium, the antibiotics gentamicin and specti-
nomycin were used at a concentration of 300 µg/ml and
erythromycin at 25 µg/ml. For E. coli, gentamicin and
spectinomycin were used at a concentration of 30 µg/ml and
100 µg/ml, respectively.
For the Rosetta-gami (DE3) pLysS E. coli protein ex-
pression strain, the following antibiotic concentrations were
used: ampicillin 100 µg/ml, chloramphenicol 50 µg/ml, tet-
racycline 12.5 µg/ml, kanamycin 15 µg/ml, and streptomycin
50 µg/ml. All antibiotics were obtained from Sigma-Aldrich
(USA).
2.2. Bioinformatic Analysis of TIR-Domain-Containing
Proteins. Putative genes encoding TIR-domain-containing
proteins were identified in the E. faecium E1162 genome
(GenBank: ABQJ00000000), and protein sequences were
found in contig107 (ABQJ01000097.1) with locus tags
EFME1162_RS19585 (old locus tag EfmE1162_2149) and
EFME1162_RS19595 (old locus tag EfmE1162_2151),
respectively.
TIR domains and protein families were verified through
searches in the Conserved Domain Database (CDD) [43].
Alignment to previously described bacterial and eukaryotic
TIR proteins (BtpA from Brucella melitensis [EXU84762.1],
TcpC from E. coli [NP_754290], YpTdp from Yersinia pestis
[WP_002213208.1], PdTir from Paracoccus denitrificans
[WP_011746463.1], TirS from S. aureus [SAS0038,
WP_000114516.1], SaTlp1 from S. aureus [CAQ50581.1],
TcpF from E. faecalis [CCO72761.1], Myd88 from Homo
sapiens [AAH13589.1], and TLR2 from Homo sapiens
[AAC34133.1]) was performed in the multiple sequence
alignment program MAFFT version 7 [44], and the align-
ment was viewed and manually curated in AliView [45]. )e
alignment was illustrated using ESPript 3.x with secondary
structure elements of BtpA [46], accessed under 4lzp in the
RCSB Protein Data Bank [47, 48]. A phylogenetic tree was
constructed with the algorithm PROTGAMMAAUTO with
100 bootstrap replicates for these protein sequences using
RAxML v8.2 [49]. )e secondary structures were predicted
in the protein fold recognition server Phyre2 [50], super-
posed to the crystal structure of the TIR domain of human
MyD88 using PDBe Fold v2.59 [51], and illustrated in
PyMOL [52].
2.3. Detection of Genes by PCR. PCR was performed with
gene-specific primers (prevalence screening primers (Table
S3)) and DreamTaq Green PCR Master Mix ()ermo
Fischer Scientific, USA) according to the manufacturer’s
instruction. One microliter of bacterial culture in BHI broth
was used as the template. A standard program of 10min
initial denaturation at 95°C followed by 30 cycles of 30 s
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denaturation at 95°C, 30 s annealing at 55°C, and 30 s
elongation at 72°C with a final elongation step for 7min at
72°C was used. PCR products were thereafter visualized on
a 1% agarose gel.
2.4. Phylogenomics. To study the distribution of tirE genes,
E. faecium genome assemblies were downloaded on June 27,
2017 (n � 516), from the National Center for Biotechnology
Information (NCBI). BLASTp [53, 54] searches were per-
formed against all the downloaded genomes for the proteins
TirE1 (EFF33949.1), Hp1 (EFF33950.1), and TirE2
(EFF33951.1). A core genome phylogenetic tree was con-
structed with all E. faecium genomes using Parsnp [55]. )e
resulting tree was visualized and annotated for the presence
or absence of tirE1, hp1, and tirE2 genes, in FigTree v1.4.3
[56]. Metadata including the country of origin, isolation
source, disease information, assembly level, and
antimicrobial-resistant phenotypes were collected for each
of the tirE-positive genomes (Table S4) from NCBI and
PATRIC [57].
2.5. Identification of a Putative Mobile Genetic Element.
)e genetic regions up- and downstream of the tirE locus in
the E. faecium E1162 genome sequence were compared to
the corresponding regions of the community strain E. fae-
cium 17OM39, which lacks the tirE region. )e comparison
was viewed and analyzed using Artemis Comparison Tool
[58]. Pairwise comparison figures were drawn using EasyFig
2.2.2 [59, 60]. Insertion of a putative mobile genetic element
in E1162 was identified, and each gene in this region was
subjected to BLAST [53] and CDD [43] searches to identify
the similar proteins and protein domains and to Phyre2 [50]
for structural, functional, and evolutionary classification
prediction (Table 1).
)e inserted genetic region that is flanked by phage
integrases was extracted from all the tirE-locus-positive
genomes. Genomes, which contained incomplete insertion
elements, because of assembly incompleteness, were ex-
cluded from further analyses. )e mobile genetic elements
were reannotated in Prokka 1.11 [61], and proteins were
clustered with Roary 3.8.2 [62]. To understand the conserved
nature of these elements, a heat map was created and vi-
sualized in GI tools [63, 64].
2.6. mRNAExpression Analysis by Reverse Transcription (RT)
PCR. For blood exposure, bacteria (E1162 and K60-39)
were grown in BHI to OD600 0.4, washed with PBS, and
resuspended in the Roswell Park Memorial Institute (RPMI)
medium with 0.05% human serum albumin (RPMI-HSA).
Fresh human blood was collected from healthy volunteers in
hirudin blood tubes (Roche Diagnostics, Switzerland),
added to the bacteria to a final concentration of 80%, and
incubated on a turning wheel at 37°C for 3 h. Blood cells were
lysed in 0.3% ice-cold saponin, and the bacterial pellet was
washed with PBS. All bacterial samples were stored in
RNAprotect solution (Qiagen, Germany). RNA was
extracted using the RNeasy Mini Kit (Qiagen, Germany)
following the manufacturer’s instructions with a prolonged
initial lysis step using mutanolysin (0.1U/µl) and lysozyme
(1mg/ml) for 1 h at 37°C. After DNase treatment (Heat and
Run Kit; ArcticZymes, Norway), RNA integrity and quantity
were checked by NanoDrop as well as on agarose gel. Re-
verse transcription was performed (High-Capacity cDNA
Reverse Transcription Kit; Applied Biosystems, USA) on
100 ng RNA, and DNA contamination was ruled out
through minus reverse transcriptase (−RT) control. )e
genes were thereafter amplified from the cDNA through
PCR (prevalence screening primers (Table S3); 30 cycles;
annealing temperature 55°C), and the products were visu-
alized on a 1% agarose gel.
In order to assess whether the genes are expressed to-
gether, junction primers were used on the cDNA template to
amplify the intergenic regions (junction primers (Table S3);
30 cycles; annealing temperature 55°C). Additionally, the
internal primers (prevalence screening primers (Table S3);
30 cycles; annealing temperature 55°C) were combined to
link the gene product. )e identity of gene products was
confirmed by sequencing the PCR products.
2.7. Cloning, Expression, and Purification of Recombinant
N-His-TirE. )e E1162 tirE1, hp1, and tirE2 genes were
amplified with BamHI-Fw and NotI-Rv primers (expres-
sion primers (Table S3)) and cloned in frame into the
expression plasmid pRSETB containing an N-terminal
HIS6 tag (Invitrogen, USA) (Table S3), as previously de-
scribed [65]. After verification of the correct sequence by
DNA sequencing, the pRSET/TirE1, pRSET/Hp1, and
pRSET/TirE2 constructs were transformed into E. coli
Rosetta-gami (DE3) plysS. Expression was induced in the
mid-logarithmic growth phase with 1mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) for 4 h or overnight (Figure
S1A).
Proteins were isolated from an HiTrap Chelating HP
column under either native (Figure S1B) or denaturing (8M
urea (Figure S1C)) conditions and eluted using an imidazole
gradient, ranging from 10 to 500mM in an ÄKTA FPLC
protein purification system (GE Healthcare Life Sciences,
Australia). )e protein-containing fractions were pooled.
Fractions containing denaturated proteins were refolded
through dialysis with salt buffer (50mM Tris and 30mM
NaCl, pH 7.8). Finally, proteins from both native and
denaturating conditions were dialyzed with PBS. )e purity
of the proteins was confirmed by SDS-PAGE.)e calculated
protein sizes with the his tag were TirE1 20.4 kDa, TirE2
34.9 kDa, and Hp1 56.9 kDa.
2.8. Anti-TirE Serum, Immunoprecipitation, and Western
Blot. Purified TirE1, Hp1, and TirE2 were then used to
immunize Enterococcus-negative rabbits by Eurogentec
(Belgium). Preimmune serum was tested for nonreactivity
towards enterococcal lysates prior to injection.
Bacteria (E1162 and K60-39) from 25ml overnight
culture were pelleted and resuspended in the lysis buffer
(lysozyme 10mg/ml and mutanolysin 6U/µl), incubated
for 1 h at 37°C, and sonicated (4 times 1min on-off).
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)e bacterial supernatant was concentrated 40 times by
centrifugation using a 10 kDa cutoff filter and sonicated (4
times 1min on-off). Immunoprecipitation was performed
using SureBeads Protein G magnetic beads (Bio-Rad, USA)
according to the manufacturer. In brief, the beads were
washed with PBS-T (PBS with 0.01% Tween), and 50% anti-
TirE1, anti-TirE2, or anti-Hp1 serum in PBS was added.
After washing three times, the bacterial lysate or supernatant
was incubated with the beads for 1 h at room temperature
under shaking. Finally, the samples were eluted into 15 µl
western blot sample buffer.
Western blot was performed as described previously
[66]. For immunodetection, the polyclonal antiserum
against TirE1 (1 : 300), Hp1 (1 : 300), and TirE2 (1 : 300) was
used. Swine horseradish peroxidase- (HRP-) conjugated
anti-rabbit IgG antibodies (1 : 3000) were used as secondary
antibodies.
2.9. Membrane Vesicle Isolation from Enterococcus.
Membrane vesicles were isolated from E. faecium as de-
scribed earlier [67]. In short, bacteria (K60-39 and DO)
were grown to the stationary phase in LB, and bacterial
cells were removed by spinning down the culture for
30min at 4°C at 6000 g. )e supernatant was filtrated
through 0.22 µm vacuum-bottle top filters (Millipore,
USA). A vesicular pellet was then obtained from the
supernatant through ultracentrifugation at 4°C at
100.000 g for 4 h, washed with PBS, and centrifuged again
at 4°C at 100.000 g for 4 h. )e vesicular pellet was
thereafter cleaned through density gradient centrifugation
using OptiPrep (Sigma-Aldrich, USA), where the MV-
containing samples were bottom loaded. 200 µl fractions
were analyzed in SDS-PAGE, and vesicle-containing
fractions were selected. Proteins were TCA precipitated
from the respective fractions and analyzed in a )ermo
Scientific Q-Exactive mass spectrometer ()ermo Fisher
Scientific, USA) after solution trypsinization.)e raw data
were processed in Proteome Discoverer 2.1 software. )e
fragmentation spectra were searched against WGS data of
the strain itself (E. faecium DO and K60-39) using the
Sequest HT program.
2.10. Markerless Mutant Construction. Utilizing the Cre-lox
recombination system, markerless gene deletion mutants in
the tirE gene cluster (locus_tag: EFME1162_RS19585 to
EFME1162_RS19595) were created as previously described
[40, 68, 69]. In short, gblock (TirE1_up-Tir2_down (Table
S3)) consisting of the 5′ and 3′ flanking regions (approxi-
mately 500 bp each) of the target with an EcoRI site between
both fragments was amplified with tirE1_up and tirE2_down
primers (Table S3) and cloned into the vector pWS3 [70],
resulting in pDELtir. )en, a gentamicin-resistant cassette
flanked by lox66 and lox71 sites [69] was cloned into the
EcoRI site included in the TirE1_up-Tir2_down gblock
between the 5′ and 3′ flanking regions in pDELtir.
)e resulting plasmid pDELtirGenta was subsequently
electroporated in competent E. faecium E1162, as previously
described. Marked mutants were obtained by growing the
gentamicin-resistant transformants at appropriate temper-
atures supplemented with respective antibiotics. )e plas-
mid pWS3-Cre carrying a gene encoding the Cre
recombinase was introduced into the marked mutant by
electroporation. Subsequent culturing to remove the
gentamicin-resistant cassette and thereby ensure loss of
pWS-Cre was performed as previously described [69]. Ex-
cision of the gentamicin-resistant cassette and loss of pWS3-
Cre were verified by PCR using the primers tirE1-check-up
and tirE1-check-down, in RT-qPCR using internal primers
(prevalence screening primers (Table S3)) as well as through
whole-genome sequencing (WGS) which also ensured that
no other mutations had occurred.
Genomic DNA of the markerless mutant was isolated
using the Wizard Genomic DNA Purification Kit (Promega,
USA) with lysozyme (20mg/ml), dissolved in water, and
sequenced by the HiSeq 2500 platform (Illumina, USA).
E. faecium and its knockout mutant genomes were
compared pairwise using Artemis Comparison Tool [58].
Pairwise comparison figures were drawn using EasyFig 2.2.2
[59]. GATK was used for variant calling to estimate the SNP
differences between these two variants [71, 72].
2.11. GFP-Expression Plasmid in Enterococcus. A pEF25
vector with GFP cloned in the SmaI site resulting in
Table 1: ORFs in the putative MGE-TirE of E. faecium strain E1162.




(secretion signal) Size (Da) Name
EFME1162_RS19580 Site-specific integrase DNA-binding integrase Integrase — 44551 int1
EFME1162_RS19585 — TIR-like TIR domain — 18496 tirE1
EFME1162_RS19590 — Sir2-like Nucleotide binding — 55003 hp1
EFME1162_RS19595 — TIR-like TIR domain — 32901 tirE2
EFME1162_RS19600 Transcription regulator DNA binding DNA binding — 9466 hp2
EFME1162_RS19605 — — — Yes 29307 hp3
EFME1162_RS0109495 — — — — 12407 hp4
EFME1162_RS19610 — — — — 8588 hp5
EFME1162_RS19615 — DnaJ super family Transcription regulator Yes 98796 hp6
EFME1162_RS0109500 — — — — 8445 hp7
EFME1162_RS19620 — — DNA binding — 34840 hp8
EFME1162_RS19625 DNA binding protein DNA binding DNA binding — 11591 hp9
EFME1162_RS19630 Transcription regulator Transcription regulator Transcription regulator — 31516 hp10
EFME1162_RS19635 Site-specific integrase Integrase Integrase — 44970 int2
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pEF451 was transformed into E. coli EC1000, as described
earlier (under submission [73]) and electroporated into
competent E. faecium E1162 and the markerless isogenic
mutant E1162ΔtirE. Transformants (GFP-E1162 and
GFP-E1162ΔtirE) were selected under antibiotic pressure
and confirmed by PCR as well as by a confocal laser
scanning microscope (CLSM Leica SP5), equipped with an
oil plan-Neofluar (×63/1.4 objective). GFP was excited at
395 nm.
2.12. Cell Lines and Culture. Peripheral blood mononuclear
cells (PBMCs) (1 × 107 cells/ml) and human neutrophils
(PMN) (5 × 106 cells/ml) were isolated from heparinized
blood as described previously [65].
All mammalian cells were grown at 37°C in an in-
cubator with 5% CO2. HEK293Tcells, a human embryonic
kidney cell line obtained from ATCC, USA, were used to
stably express human TLR2, as described previously
(under submission [74]). In short, human TLR2
(NM_003264.3) was cloned and its signal peptide (aa1-20)
was replaced by the PreProTrypsin signal peptide
(MSALLILALVGAAVA), adapted from the pFLAG-
CMV-1 vector (Sigma-Aldrich, USA). To the N-termi-
nus, a FLAG tag (DYKDDDDK) followed by a flexible
linker (GGS) was attached. For stable expression in
HEK293T cells, a lentiviral expression system was used.
)e FLAG tag was detected using anti-FLAG M2 antibody
(Sigma-Aldrich, USA), subsequently stained with
phycoerythrin-labeled goat-anti-mouse antibody, and
detected on a flow cytometer (FACSVerse, BD Biosciences,
USA). )e HEK293T-TLR2 cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) with 10% (v/v)
fetal calf serum (FCS) (Invitrogen Life Technologies, USA)
and 100 units/ml of penicillin and streptomycin (Sigma-
Aldrich, Germany).
)p-1 cells (ATCC, USA), a human monocytic cell
line, were maintained in the RPMI 1640 medium with
2mM L-glutamine supplemented with 10% (v/v) fetal
bovine serum (FBS; Biowest, USA), 10mM HEPES, 1mM
sodium pyruvate, 4.5 g/L glucose, and 0.05mM beta-
mercaptoethanol (all from Gibco, Life Technologies,
USA). For differentiation of )p-1 to macrophage-like
cells, RPMI 1640 with 2mM L-glutamine without phenol
red was used with the same supplements as above, but with
addition of 25 nM phorbol 12-myristate 13-acetate
(PMA).
2.13. Cytokine Production upon E. faecium Infection. )e
effect of the tirE locus on cytokine release was investigated
by measuring IL-8 release upon )p-1 infection with the
E. faecium wildtype strain E1162 or E1162ΔtirE.
Bacteria were grown in BHI to OD600 0.4, washed with
PBS, and resuspended in the cell culture medium and diluted
to the appropriate CFU/ml.
)p-1 cells were seeded in a 24-well plate in RPMI at 1 ×
105 cells per well and differentiated for 24 h by addition of
25 nM PMA. For infection, 100 µl of bacterial suspension
(equal to MOI 300, MOI 100, and MOI 10) was added per
cell culture well and incubated for 37°C.)e supernatant was
collected after 2, 4, and 6 h, and debris was spun down at
13000 rpm at 4°C.
IL-8 within the supernatant was detected using the IL-8
ELISA Kit ()ermo Fisher Scientific, USA) following the
manufacturer’s instructions. Absorbance was measured at
450 nm.
2.14. Interference with Ligand-Induced Cytokine Production.
Mammalian cells were plated out at 2.5 × 104 cells/well in
a 96-well culture plate 24 h prior to the experiment to reach
confluence. )e inhibitor (TirEs and/or Hp1 or SSL3 [75])
was added at a final concentration of 10 µg/ml, and the cells
were incubated at 37°C for 1 h. After 6 h incubation with
stimulus (3 ng/ml MALP-2 (Santa Cruz, USA); 3 ng/ml
PAM-2-Cys and 3 ng/ml PAM-3-Cys (EMC Micro-
collections, Germany), the supernatant was collected and
IL-8 was measured using a specific IL-8 ELISA Kit (San-
quin, the Netherlands) following the manufacturer’s in-
structions. In short, Nunc MaxiSorp plates were coated
with anti-IL-8, washed and blocked with 4% nonfat dry
milk in PBS-T, and washed again and incubated with the
supernatant in high-performance ELISA (HPE) buffer at
37°C for 1 h. After washing, biotinylated anti-IL-8 and
subsequently streptavidin-HRP were added. Tetrame-
thylbenzidine (TMB) was used as the substrate, and the
reaction was stopped with sulfuric acid as soon as a change
in color was visible. OD450 was measured for
quantification.
2.15. Serum-Dependent Phagocytosis in Flow Cytometry.
Blood was collected from healthy volunteers and allowed to
clot. After centrifugation, the human serum was collected
and pooled. )e serum was stored at −70°C. When re-
quired, heat inactivation of serum was performed at 56°C
for 30min.
GFP-E1162 and GFP-E1162ΔtirE were grown in BHI to
OD600 0.4, washed with PBS, and exposed to serum for
15min at 37°C in a 96-well round bottom plate (Greiner,
Austria) on a shaking plateau prior to phagocytosis.
PMNs and PBMCs (200 µl and 300 µl, respectively) were
added to the bacteria, and the cells were coincubated for
15min at 37°C. )e cells were thereafter fixed in 1.5%
paraformaldehyde in RPMI-HSA, and fluorescence was
measured through flow cytometry (FACSCalibur; Becton
Dickinson, USA).
2.16. Intracellular Survival within Macrophages.
Intracellular survival was assessed in a gentamicin-
vancomycin protection assay. )p-1 cells were seeded in
a 12-well plate in RPMI with the required supplements at 1 ×
106 cells per well and differentiated for 24 h by addition of
25 nM PMA. Bacteria were grown in BHI to OD600 0.4,
washed with PBS, and resuspended in the cell culture me-
dium. For infection, 200 µl of bacterial suspension was added
per cell culture well and incubated for 1 h. After PBS washing
of )p-1 cells, 16 µg/ml vancomycin and 150 µg/ml
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gentamicin were added to the wells in order to kill the
extracellular bacteria. )p-1 cells were thereafter harvested
after 24, 48, 72, and 120 h and lysed in 0.3% saponin. )e
released intracellular bacteria were plated on blood agar
plates and counted.
2.17. Whole-Blood Phagocytosis and Blood Survival Assay.
GFP-E1162 and GFP-E1162ΔtirE from a blood agar plate
were diluted in BHI to OD600 0.1 and grown at 37°C to OD600
0.4, washed with PBS, and resuspended in RPMI-HSA.
Blood was obtained from a healthy volunteer in a hirudin
blood tube (Roche Diagnostics, Switzerland) and diluted in
RPMI-HSA. For all whole-blood experiments, blood was
used at 80% if not otherwise indicated.
Phagocytosis was performed in round-bottom poly-
styrene tubes under rigorous shaking at 37°C for 20min.
Erythrocytes were lysed by adding FACS lysing solution
(BD) for 20min at 25°C. )e remaining immune cells were
washed with RPMI-HSA and fixed in 150 µl 1% para-
formaldehyde in RPMI-HSA. Fluorescence was measured
through flow cytometry (FACSCalibur; Becton Dickinson,
USA).
For blood survival assays, E1162 and E1162ΔtirE were
grown in BHI to OD600 0.4, washed with PBS, and incubated
with 80% fresh hirudin blood in siliconized tubes (Sigma-
Aldrich, USA) on a turning wheel at 37°C for 3 h, if not
otherwise indicated. Blood cells were lysed in 0.3% saponin,
and CFUs were counted on blood agar plates.
2.18. Statistical Analysis andDataValidation. Statistical data
analysis was performed in GraphPad Prism 7. )e presented
data are expressed as mean ± SEM of pooled experiments.
Blood experiments were performed at least in 3 different
donors, representing both male and female.
2.19. Ethics Statement. )e human blood analysis was car-
ried out in accordance with ethical principles of the Helsinki
Declaration, the Medical Ethics Committee of the University
Medical Center Utrecht (the Netherlands), and ethical ap-
proval of (2014/1653) REK North-Norway with written
informed consent of participants.
3. Results
3.1. Identification and Predicted Tertiary Structure of TirEs.
Two putative proteins annotated with a TIR domain were
identified in E. faecium in the protein database at NCBI.
)ese two open reading frames (ORFs) were found, with
a hypothetical protein (hp1) in between them. In E. faecium
E1162, the TIR-domain-containing locus tags EFM-
E1162_RS19585 and EfmE1162_RS19595 span 492 and
864 bp, respectively. In line with previous studies [19], the
protein-encoding genes were designated tirE1 and tirE2. )e
predicted mass of TirE1 was 18.5 kDa, TirE2 32.9 kDa, and
Hp1 55.0 kDa (Table 1). )e TIR-domains were verified
through the CDD search [43] and found to belong to the
protein families pfam08937 (TirE1) and pfam13676 (TirE2).
Amino acid sequence alignment of multiple bacterial
TIR-domain-containing proteins showed high conservation
of the TIR domain across species. Amino acid sequence was
particularly conserved in boxes 1 and 2, as well as in the
WxxxE motif. In TirE1, the WxxxE motif has a tyrosine
instead of tryptophan, but both amino acids are aromatic.
)e WxxxE motif has been found in most bacterial TIR-
domain-containing proteins including PdTir, SaTlp1, and
TlpA, as well as eukaryotic TLR proteins TLR1, 2, 4, 6, and
10 and TIR adaptor protein SARM [76] (Figure 1(a)).
Variability was observed in the region between strand βB
and helix αB, the so-called BB loop (Figure 1(a)). )e in-
dicated BB loop has been described to be surface-exposed
and essential for homotypic TIR-domain interactions in
TLR/IL-1R signaling [77]. )e predicted tertiary structure of
both TirEs (Figure 1(b)) shows a typical flavodoxin-like TIR
fold, with central parallel β-sheets surrounded by α-helices
on both sides of the sheet [77].
A phylogenetic tree illustrating the relatedness of the
aligned TIR-domain-containing proteins to each other
showed that the human TLR2 andMyD88 are grouped in the
same cluster, whereas the bacterial TIR-domain-containing
proteins group in different clusters (Figure S2). Even though
both TirE1 and TirE2 originate from E. faecium, they fall into
two different clusters, indicating that these are probably not
just gene duplications but two different genes.
3.2. #e tirE Locus Is Prevalent in Nosocomial but Absent in
Community Isolates. A total of 1194 E. faecium isolates
were screened for tirE1, tirE2, and hp1 either by regular
PCR using prevalence screening primers or by BLAST
searches in sequenced isolates. tirE1, hp1, and tirE2 genes
were found to be highly prevalent in blood culture isolates
(tirE1 37%, hp1 36%, and tirE2 35%), and among those, the
dominant STs were ST17, ST203, and ST192. )e genes
were also frequent in other hospital-associated samples
(tirE1 32%, hp1 22%, and tirE2 31%) with the most
prevalent STs being ST78, ST389, and ST192. 84 of the
hospital screening samples were positive for tirE1 and
tirE2, but lacked hp1, which coincides with the presence of
vanB vancomycin-resistant cluster in 79 of them (Table S1).
Contrasting the high prevalence in blood culture isolates
and other hospital-associated samples, the three genes were
absent in community isolates (Figure 2).
Furthermore, BLAST search revealed that the tirE locus
was found in 14% of 460 draft genome sequences of nos-
ocomial strains, while these genes were absent in draft ge-
nome sequences of all 56 community strains (Figure S3).
)is dichotomy in the presence of the tirE locus between
hospital and community isolates suggests that the possession
of the tirE locus is beneficial for the bacterium in the hospital
setting.
3.3. #e tirE Locus Is Localized on a Putative Mobile Genetic
Element of Phage Origin. Analysis of the genetic sur-
roundings of the tirE locus suggested that the genes were
localized on a putative mobile genetic element flanked by
two integrases. )is putative MGE was designated MGE-
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TirE (for mobile genetic element containing tirEs). Pairwise
comparison of the genomic region encompassing MGE-TirE
in the strain E1162 with the community strain E. faecium
17OM39 which does not contain the tirE locus revealed the
MGE-TirE’s size of 14.425 kbp and site of integration
(Figure 3(a)). )e putative function of the ORFs (n � 13)
within MGE-TirEs is indicated in Figure 3(a) and in Table 1.
Six of the ORFs were predicted to encode either tran-
scription regulators (n � 2) or DNA-binding proteins (n �
4). 31% the GC content of MGE-TirE is especially low (GC
content calculated in 4 representative strains), since the
average GC content for E. faecium is 38% [78].)e twoORFs
flanking MGE-TirE were predicted to encode putative
integrases. )ey both showed high similarity to phage
integrases. Furthermore, one of the hypothetical proteins
(hp9) was similar to a Lactobacillus plantarum prophage
remnant LP4 protein [79]. BLAST analyses of the region as

























Figure 1: Secondary and tertiary structure prediction of TirEs. (a) Primary amino acid sequence alignment of TirE1 and TirE2 to bacterial
TIR-domain-containing proteins and human TIR-domain-containing proteins. )e region shown displays the TIR domain as predicted by
CDD. Similar and identical residues are depicted in red and boxed in blue. Conservation in regions such as Box1, Box2, and the WxxxE
motif is marked. )e corresponding secondary structure elements of BtpA as determined by X-ray crystallography are shown on top of the
alignment. (b) Predicted tertiary structures of TirE1 and TirE2 compared to the crystal structure of the TIR domain of MyD88. Key
secondary structures are labeled; α-helices are shown in blue, β-sheets in cyan, and loops in green. )e BB loop as a divergent structure is
marked.
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NCBI nonredundant database or the Sequence Read Ar-
chive. )e deviant GC value and putative function of ORFs
indicated presence of foreign genes, possibly of phage
origin.
MGE-TirE was probably acquired multiple times during
E. faecium evolution, as it occurs in different branches of
the core genome phylogenetic tree (Figure S3). Moreover,
MGE-TirE was integrated at an identical site adjacent to the
host phage integrase gene (int1) in all the TirE-positive
genomes, indicating site-specific integration. To describe
the conservation of the content of MGE-TirE, a heat map
was created, illustrating that most of the genes identified as
part of MGE-TirE were highly abundant within the indi-
vidual elements of all MGE-TirE-containing strains, in-
cluding the integrases and TIR-domain-containing
proteins (Figure 3(b)).
3.4. Expression of Genes of the tirE Locus. RT-PCR revealed
that the genes of the tirE locus are expressed in both E1162
and K60-39. Expression was detected in the stationary phase
in BHI and upon exposure to human blood for 3 h; all three
genes showed enhanced expression in E1162 (Figure 4).
Promoter prediction analysis revealed only weak promoters
between the three genes of the tirE locus, so a linking RT-
PCR, where the chosen primers hybridize to the different
genes, was performed to determine whether the genes are
part of a single operon (Figure 5(a)). )e junctions of tirE1
and hp1 as well as hp1 and tirE2 gave products (Figure 5(b)),
whereas the outward-pointing junctions did not (data not
shown). Sequencing confirmed the identity of the PCR
products (data not shown). )is indicates that the two tirEs
and hp1 encoded by the same strand are transcribed
together.
3.5. tirE-Locus-Encoded Proteins Are Released into Superna-
tant and Associated with Membrane Vesicles. Since there
were no signal peptide cleavage sites predicted by SignalP in
TirEs and Hp1, it was an open question whether bacteria
were able to release these proteins (Table 1). Antibodies
against TirEs and Hp1 were specific but unfortunately had
low sensitivity (results not shown). In order to detect protein
release, anti-TirE/Hp1 serum was used to immunoprecipi-
tate the proteins from the bacterial lysate and supernatant.
)e immunoprecipitated proteins were thereafter detected
by immunoblot. All three proteins were detected in the cell
lysate as well as in the supernatant of both E1162 and K60-39
cultures, indicating release through an unknownmechanism
(Figures 6(a)–6(c)).
Membrane vesicles (MVs) have previously been sug-
gested as a secretory system [80]. TirE2 and Hp1 were
found to be associated with MVs from K60-39 and DO.
)e exponentially modified protein abundance index
(emPAI) value for TirE2 was 0.389 and for HP1 was 0.089
(Figure 6(d)). )e identification confidence was character-
ized as “high” in the protein false discovery rate (FDR)
confidence, and the FDR was lower than 1% with 1 peptide
and 2 peptide-to-spectrum matches [67].
3.6. Construction of a tirE1-hp1-tirE2 Knockout Strain for
Functional Studies. A markerless mutant lacking the tirE
locus was constructed and confirmed by PCR, gene ex-
pression, and whole-genome sequencing (Figures S4A–C).
Comparison of the whole-genome sequences of the wildtype
strain (E1162) and mutant strain (E1162ΔtirE) confirmed
the absence of tirE1-hp1-tirE2 (Figure S4C), and except for
these three genes, the strains share 99% nucleotide identity
(data not shown). )e deletion of tirE1-hp1-tirE2 did not
affect the bacterial growth in BHI (Figure S4D). Un-
fortunately, we did not succeed in constructing single gene
knockouts nor in complementing the deletion, probably
because there were repetitive sequences in this gene region
and it has a very low GC content.
3.7. #e tirE Locus Does Not Interfere with Cytokine Release.
Differentiated )p1 cells were infected with E1162 or its
isogenic mutant E1162ΔtirE at MOI 10, 100, and 300. )e
IL-8 was then detected in the supernatant. As seen in
Figure 7(a), E1162 and E1162ΔtirE at all MOIs induced IL-8
release in a similar way.
To examine whether TirEs are capable of interfering
with TLR2 signaling, HEK293T cells stably expressing
TLR2 were stimulated with the synthetic lipopeptides
MALP-2, Pam2Cys, and Pam3Cys in the presence or
absence of the recombinant TirEs and Hp1, which was
added to the cells before stimulation. IL-8 was measured in
the supernatant through ELISA. TirE1 and TirE2 both
inhibited Malp2-, Pam2Cys-, and Pam3Cys-induced TLR2
activation significantly (Figure 7(b)). )is effect was
similar to the inhibition by SSL3, a well-known staphy-
lococcal inhibitor of TLR2 signaling [75]. However, the
combination of TirE1, Hp1, and TirE2 had no inhibitory











Figure 2: Prevalence of the genes tirE1, hp1, and tirE2 in human
E. faecium isolates. Percentage indicates the amount of isolates
positive for tirE1, hp1, and tirE2 among blood culture isolates (n �
161), other hospital-associated isolates (n � 875), and community
isolates (n � 158).
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3.8.#e tirE Locus Does Not Have an Effect on Phagocytosis or
Bacterial Survival within Macrophages. Since phagocytosis
of enterococci is serum dependent [81–83], the effect of the
possession of the tirE locus on serum-induced phagocytosis
was further examined. Hence, the GFP-expressing en-
terococci (GFP-E1162 and GFP-E1162ΔtirE) were in-
cubated for 1 h in human blood, before the level of
fluorescent bacteria within PMNs was analyzed by flow
cytometry. )ere was no significant difference in the level
of phagocytosis of the wildtype strain and its isogenic
mutant (Figure S5A). )e experiment was then repeated
using blood cells. Here, GFP-E1162 and GFP-E1162ΔtirE
were opsonized by adding 50% or 100% serum before being
exposed to human PMNs and PBMCs. Again, there was no
significant difference between the phagocytosis of GFP-
E1162 and GFP-E1162ΔtirE (Figure S5B). )is clearly
shows that the tirE locus does not influence the host-
mediated phagocytosis of the bacteria.
Next, the role of the tirE locus for intracellular survival in
macrophages was investigated. E1162 and E1162ΔtirE
enterococci were coincubated with )p-1 over time, before
being plated out for CFU determination. 0.5% of E1162 and
E1162ΔtirE survived after 24 h, and after 120 h, very few
bacteria had survived. )e presence or absence of the tirE
locus did not have any effect on the ability of the bacteria to
survive in macrophages (Figure S6).
3.9. Presence of the tirE Locus Enhances Bacterial Survival and
Proliferation in Blood. Finally, it was evaluated whether the
presence of the tirE locus plays a role in E. faecium’s survival
in blood. E1162 and E1162ΔtirE were incubated in human
whole blood for 3 h before plating for CFU determination.
)ewildtype strain showed a 19-fold increase in CFU over the
blood incubation, while its isogenic mutants showed only
a 13-fold increase in CFU (Figure 8(a)). Additionally, the
differences in survival and replication between E1162 and
E1162ΔtirE increased over time (up to 6 h) (Figure 8(b)). )is
suggests that the presence of the tirE locus is beneficial for
bacterial growth in human blood.


























Figure 3: Comparative genomics ofMGE-TirE insertion and relative abundance of MGE genes. (a) Pairwise alignment of E1162, containing
MGE-TirE (top), and 17OM39. MGE-TirE is flanked by two integrases (cyan) and contains in total 14 open reading frames, color-coded by
putative function. tirEs are shown in blue, putative DNA-binding hypothetical proteins in dark green, and putative transcription regulators
in light green, hypothetical proteins (hp) for which no function could be predicted in grey. On top of the alignment, the GC abundance is
illustrated in green. )e black line refers to 50% GC. )e percentage of nucleotide identity in forward and reverse strands is represented in
light orange and dark orange, respectively, as shown in the bottom right of the alignment. (b) Gene presence/absence withinMGE-TirE in 42
strains (top). Genes are color coded by the putative function of the proteins they encode (the same color code as in (a)).
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4. Discussion
)e pronounced increase in bacteremia caused by E. faecium
[7, 84] and the limited knowledge about enterococcal vir-
ulence factors led to the search for TIR-domain-containing
proteins in this species. )is study identified a tirE locus
encoding two TirE proteins and an intermediate protein
Hp1. )e tirE locus was prevalent in nosocomial isolates but
absent in commensals (Figure 2) and located on a putative
mobile genetic element of phage origin (Figure 3). )e three
genes may be expressed as an operon (Figure 5), and
presence of all three proteins was confirmed in the bacterial
cell lysate and supernatant (Figure 6). Moreover, the tirE-
locus genes were expressed when bacteria were exposed to
blood (Figure 4), and the presence of the tirE locus increased
bacterial proliferation in blood (Figure 8).
Hp1 intersected the two genes encoding the two TirE
proteins presented here. Since we were able to link two of
these genes by RT-PCR and no strong promoter was
identified between the genes, we suggest that they are
expressed as one operon. )e tirE locus was found on
a putative mobile genetic element. )e element is putatively
of phage origin because of its low GC content and the
presence of phage proteins. Likewise, tcpF of E. faecalis is
found in a hotspot of recombination events of phage origin
[24]. In fact, it has been observed multiple times that bac-
terial tir genes are found in regions of phage origin, e.g., tlpA
(S. enterica) [18], tcpC (E. coli) and tcpB (Brucella) [85], or on
mobile elements such as tirS (S. aureus) on SCC [86]. )us,
lateral transfer of bacterial tir genes is likely. Furthermore,
the putative MGE-TirE appeared in multiple branches
within the E. faecium phylogenetic tree (Figure S3),
indicating horizontal gene transfer. However, it cannot be
concluded whether the element was acquired or lost several
times.
A high prevalence of the tirE locus was found in clinical
and blood culture isolates, whereas the genes are absent in
community isolates (Figure 2). Similar observations were
made for tcpC, which was present in 40% of uropathogenic
strains versus 8% in commensal strains [85]. TcpF is pre-
dominant among urinary tract infection isolates but also
frequent in commensal isolates (76% in invasive versus 58%
in commensal strains) [21]. )is could however be explained
by the differences in the clade structure of E. faecium and
E. faecalis: while E. faecium is characterized by host-specific
lineages and clades, with a clearly distinct clade (A1) of
isolates originating from hospitalized patients, this di-
vergence is not seen in E. faecalis [1, 87]. In this context, it
makes sense that E. faecium tirE is not found in community
isolates, while E. faecalis tcpF is. For E. faecalis, it was
suggested that the possession of the tcpF gene is also ben-
eficial in community isolates, since the homeostasis in the
gastrointestinal tract is crucial for commensals. Accordingly,
avoiding NFkB activation through TLR signaling inhibition
reduces the risk of homeostatic imbalance [21]. Besides the
high prevalence of the tirE-locus genes in clinical and blood
culture, it was observed that 10% of the hospital screening
samples positive for tirE1 and tirE2, but lacking hp1, were
also positive for the vanB vancomycin-resistant cluster
(Table S2). hp1, alias HMPREF0351_10592, was previously
described as an insertion site for the conjugative vanB
transposon Tn1549/5382 in different strain backgrounds
(ST192, ST78, ST927, and ST202 isolates) [88]. )is vanB
transposon has also been shown to prefer AT-rich sequences
E1162
gDNA









































Figure 4: Expression of genes tirE1, hp1, and tirE2 upon exposure of E. faecium to blood. RT-PCR products of E1162 and K60-39 grown to
the stationary phase in BHI and upon 3 h exposure to human blood of two different donors are photographed. −RTshows the control of the
PCR reaction without reverse transcriptase.
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[89], and the putative MGE-TirE with its 31% GC content is
AT enriched. However, it remains to be investigated by
future studies whether hp1 provided an insertion site for the
vanB transposon in our strain collection.
No direct bacterial contact with the host cell is needed
to exert the function of bacterial TIR-domain-containing
proteins, e.g., for E. coli TcpC [90] and S. aureus TirS [19],
and bacterial TIR-domain-containing proteins have been
detected inside host cells previously [85]. However, most of
the bacterial TIR-domain-containing proteins lack secretion
signals [22], and how the proteins are released and trans-
ferred to other cells remains largely unknown. Here, we
detected all tirE-locus-encoded proteins in the bacterial
supernatant and demonstrated that TirE2 and Hp1 can be
found associated with bacterial MVs. Similarly, S. aureus
TirS was also associated with MVs isolated from bacteria
grown in BHI (results not shown). )is might suggest that
bacterial TIR-domain-containing proteins can be released
through MVs. In order to test this hypothesis, the vesicular
proteomic contents of other tir-gene-possessing bacteria
should be evaluated and compared to the nonmembrane
bound secretome.
)is study found that purified TirEs negatively interfere
with IL-8 release of HEK293T cells expressing TLR2 when
added to the cell cultures prior to stimulation with its specific
ligands (Figure 7(b)). )ese findings are in line with results
fromNFkB-reporter assays for E. faecalis TcpF, conducted in
hTLR2-expressing HEK293 cells stimulated with PamCys3
[21], and with similar studies on S. aureus TirS [19, 86].
Bacterial TIR-domain-containing proteins from Gram-
negative bacteria [18, 22, 90] have also been shown to im-
pede the host innate immune response through interference

























Figure 5: Both tirEs are part of one operon within E1162. (a) Graphical representation of the tirE operon within E1162 and primer
locations. )e ORFs in the immediate surrounding of tirEs are shown by thick arrows, while thin grey and black arrows indicate the
location and orientation of the primers used for RT-PCR. Amplification is indicated as a straight line, and crossed lines indicate absence
of products. Grey lines and arrows illustrate junction primers amplifying intergenic regions and their products. Black lines and arrows
show the internal primers and their products, which were used to confirm linkage of the gene expression. (b) RT-PCR products linking
tirE1, hp1, and tirE2. RT-PCR after amplification with tirE1 internal (TirE1-F) plus hp1 internal (Hp-R) primers yielded a 777 bp band
and with hp1 internal (Hp-F) plus tirE2 internal (TirE2-R) gave a 1286 bp product. −RT shows corresponding negative controls and
gDNA positive controls.
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with TLR signaling. )e inhibitory effect of TirEs on IL-8
release was abolished when a combination of TirEs and Hp1
was used. Similarly, there was no difference in cytokine
release in macrophage-like cells infected with E1162 or
E1162ΔtirE (Figure 7(a)). )e mechanism behind this
phenomenon is elusive but might involve a regulatory role of
Hp1. Unfortunately, it was not possible to make single
knockouts to distinguish between effects of the proteins.
Two staphylococcal TIR-domain-containing proteins,
SaTlp1 and SaTlp2, found in zoonotic ST398, also showed
a deviation from the typical theme: they upregulated NFkB








1 2 3 4 5 6 7 8 9 M





















21 3 4 5 6 7 M8 9
SP

















Figure 6: Detection of TirEs and Hp1 in the bacterial cell lysate, supernatant, and MV. (a–c) TirE1 (18.5 kDa), Hp1 (55 kDa), and TirE2
(33 kDa) were immunoprecipitated from the lysed pellet (P) or bacterial supernatant (S) after 4 h or from overnight culture (on) and
detected in western blot with anti-TirE1, anti-Hp1, or anti-TirE2 serum. Shown are samples from the E1162 and K60-39, purified proteins
(TirE1 with his tag 20.4 kDa (lane 5 in (a)), Hp1 with his tag 57 kDa (lane 5 in (b)), and TirE2 with his tag 35 kDa (lane 5 in (c))), and Magic
marker (M) with size indicated in kDa. (d) EmPAI values indicating the protein abundance of TirE1, Hp1, and TirE2 proteins in membrane
vesicles derived from K60-39 and DO.
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Figure 7: Effect of TirEs andHp1 on IL-8 release. (a) Presence of tirE1-hp1-tirE2 does not affect IL-8 release. Upon infection of macrophage-
like cells (differentiated )p1 cells) with E1162 and E1162Δtir at MOI 300, MOI 100, and MOI 10, IL-8 was measured in the cellular
supernatant at 2 h, 4 h, and 6 h after infection, through IL-8 ELISA. Data are pooled from 3 independent experiments, each in duplicates.
(b) Interference of TirE1 and TirE2 with TLR2 signaling. IL-8 release was measured as a response of HEK293 cells stably expressing TLR2
towards stimulation with the lipoproteins Malp2, Pam2Cys, and Pam3Cys. )e cells were left untreated (nonstimulated) or were added
Malp2, Pam2Cys, or Pam3Cys. One hour before stimulation with agonists, the TLR2-expressing HEK293 cells were added SSL3 (well-
known inhibitor of TLR2 signaling), TirE1, TirE2, or a combination of TirE1, Hp1, and TirE2 to a final concentration of 10 µg/ml. IL-8 was
quantified in IL-8 ELISA, using TMB as the substrate and measuring the absorbance at 450 nm. Data are shown in triplicates, representative
of 3 independent experiments. ∗P≤ 0.05, inhibited vs uninhibited: PTir1Malp2 � 0.051, PTir1Pam2 � 0.045, PTir1Pam3 � 0.017, PTir2Malp2 � 0.049,




































Figure 8: Presence of tirE1-hp1-tirE2 increases bacterial survival and proliferation in human whole blood ex vivo. (a) tirE1-hp1-tirE2
enhances bacterial proliferation in human whole blood. After 3 h of exposure of E1162 and E1162ΔtirE to whole blood, the fold change in
CFU is significantly higher for E1162 compared to E1162ΔtirE, where the inoculum is set as 1. Data shown represent pooled data from 3
donors (inoculum 20 µl at OD600 0.4, t-test, 2-tailed, P3h � 0.002). (b) tirE1-hp1-tirE2 enhances proliferation in human whole blood over
time. E1162 and E1162ΔtirE were incubated in blood for indicated time points. Data represent quadruplicates from one healthy donor and
are representative of 3 independent experiments in different donors. (inoculum � 20 µl at OD600 0.4, t-test, P3.5h � 0.0328, P6.3h < 0.0001).
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In E. faecium, the tirE locus promoted bacterial pro-
liferation in human blood (Figure 8) and blood also induced
tirE expression (Figure 4). )is suggests that the tirE locus
provides E. faecium with an advantage of surviving in blood
by interfering with TLR-2 signaling. )is could also explain
the predominance of tirE and hp1 in blood culture and
hospital isolates.
5. Conclusion
)e presented study describes TirEs, E. faecium TIR-
domain-containing proteins, as novel virulence factors.
)e tirE locus is exclusive of E. faecium nosocomial
isolates and located on a putative mobile genetic element
of phage origin. Bacterial proliferation within human
blood is enhanced by possession of the tirE locus, im-
plicating a role of TirEs in bacteremia and the pathoge-
nicity of E. faecium.
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